thoughts on fair market cap assuming trials replicate or improve on results already seen?
It’s obviously a bit of an art at this early stage, but since buying soon after IPO I’ve had $120m as a target that I think is not unreasonable considering peers and realistic chance of revenues flowing by 2026
keen to hear views of others
above not financial advice!
Ann: Trading Halt, page-14
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add LTP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
78.0¢ |
Change
-0.010(1.27%) |
Mkt cap ! $54.91M | |||
| Open | High | Low | Value | Volume |
| 80.0¢ | 81.0¢ | 75.0¢ | $296.4K | 380.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9999 | 78.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 78.5¢ | 2873 | 1 |
View Market Depth
| Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
| LTP (ASX) Chart |